BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Jaber V, Alexandrov PN, Vergallo A, Lista S, Hampel H, Lukiw WJ. microRNA-Based Biomarkers in Alzheimer's Disease (AD). Front Neurosci 2020;14:585432. [PMID: 33192270 DOI: 10.3389/fnins.2020.585432] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Suster I, Feng Y. Multifaceted Regulation of MicroRNA Biogenesis: Essential Roles and Functional Integration in Neuronal and Glial Development. Int J Mol Sci 2021;22:6765. [PMID: 34201807 DOI: 10.3390/ijms22136765] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Nagaraj S, Want A, Laskowska-Kaszub K, Fesiuk A, Vaz S, Logarinho E, Wojda U. Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression. Int J Mol Sci 2021;22:3653. [PMID: 33915734 DOI: 10.3390/ijms22073653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Combi R, Salsone M, Villa C, Ferini-Strambi L. Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges. Int J Mol Sci 2021;22:3960. [PMID: 33921279 DOI: 10.3390/ijms22083960] [Reference Citation Analysis]
4 Jia L, Zhu M, Yang J, Pang Y, Wang Q, Li T, Li F, Wang Q, Li Y, Wei Y. Exosomal microRNA-based predictive model for preclinical Alzheimer’s disease: a multicenter study. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2021.12.015] [Reference Citation Analysis]
5 Lukiw WJ. Fission Impossible: Stabilized miRNA-Based Analogs in Neurodegenerative Disease. Front Neurosci 2022;16:875957. [DOI: 10.3389/fnins.2022.875957] [Reference Citation Analysis]
6 Li Y, Han X, Fan H, Sun J, Ni M, Zhang L, Fang F, Zhang W, Ma P. Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer’s disease. Neuroscience Letters 2022. [DOI: 10.1016/j.neulet.2022.136531] [Reference Citation Analysis]
7 Siedlecki-Wullich D, Miñano-Molina AJ, Rodríguez-Álvarez J. microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective. Cells 2021;10:113. [PMID: 33435363 DOI: 10.3390/cells10010113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Campese N, Beatino MF, Del Gamba C, Belli E, Giampietri L, Del Prete E, Galgani A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F. Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer's and other neurodegenerative diseases. Expert Rev Neurother 2021;:1-19. [PMID: 34365867 DOI: 10.1080/14737175.2021.1965879] [Reference Citation Analysis]
9 Perdoncin M, Konrad A, Wyner JR, Lohana S, Pillai SS, Pereira DG, Lakhani HV, Sodhi K. A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders. Front Mol Neurosci 2021;14:756499. [PMID: 34690698 DOI: 10.3389/fnmol.2021.756499] [Reference Citation Analysis]
10 Ramaswamy P, Christopher R, Kumar Pal P, Debnath M, Yadav R. Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy. Diagnostics 2022;12:1204. [DOI: 10.3390/diagnostics12051204] [Reference Citation Analysis]
11 Giuliani A, Gaetani S, Sorgentoni G, Agarbati S, Laggetta M, Matacchione G, Gobbi M, Rossi T, Galeazzi R, Piccinini G, Pelliccioni G, Bonfigli AR, Procopio AD, Albertini MC, Sabbatinelli J, Olivieri F, Fazioli F. Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease. Front Aging Neurosci 2021;13:647015. [PMID: 33776746 DOI: 10.3389/fnagi.2021.647015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhang M, He P, Bian Z. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers. Front Mol Neurosci 2021;14:685143. [PMID: 34421536 DOI: 10.3389/fnmol.2021.685143] [Reference Citation Analysis]
13 Li G, Liang R, Lian Y, Zhou Y. Circ_0002945 functions as a competing endogenous RNA to promote Aβ25-35-induced endoplasmic reticulum stress and apoptosis in SK-N-SH cells and human primary neurons. Brain Research 2022. [DOI: 10.1016/j.brainres.2022.147878] [Reference Citation Analysis]
14 Vergallo A, Lista S, Zhao Y, Lemercier P, Teipel SJ, Potier MC, Habert MO, Dubois B, Lukiw WJ, Hampel H; INSIGHT-preAD study group., Alzheimer Precision Medicine Initiative (APMI). MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints. Transl Psychiatry 2021;11:78. [PMID: 33504764 DOI: 10.1038/s41398-020-01184-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mogavero MP, Silvani A, DelRosso LM, Salemi M, Ferri R. Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity. Cancers (Basel) 2021;13:2612. [PMID: 34073579 DOI: 10.3390/cancers13112612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yacovzada NS, Hornstein E. microRNAs trip down memory lane. EMBO Mol Med 2021;13:e14997. [PMID: 34672084 DOI: 10.15252/emmm.202114997] [Reference Citation Analysis]
17 Turk A, Kunej T, Peterlin B. MicroRNA-Target Interaction Regulatory Network in Alzheimer's Disease. J Pers Med 2021;11:1275. [PMID: 34945753 DOI: 10.3390/jpm11121275] [Reference Citation Analysis]
18 Dong X, Cong S. MicroRNAs in Huntington's Disease: Diagnostic Biomarkers or Therapeutic Agents? Front Cell Neurosci 2021;15:705348. [PMID: 34421543 DOI: 10.3389/fncel.2021.705348] [Reference Citation Analysis]
19 Mankhong S, Kim S, Lee S, Kwak H, Park D, Joa K, Kang J. Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers. Biomedicines 2022;10:850. [DOI: 10.3390/biomedicines10040850] [Reference Citation Analysis]
20 Zheng Y, Xu Q, Jin Q, Du Y, Yan J, Gao H, Zheng H. Urinary and faecal metabolic characteristics in APP/PS1 transgenic mouse model of Alzheimer's disease with and without cognitive decline. Biochem Biophys Res Commun 2022;604:130-6. [PMID: 35303679 DOI: 10.1016/j.bbrc.2022.03.048] [Reference Citation Analysis]